Drug Profile
Research programme: pyrrolobenzodiazepine based therapeutics - BetterLife Pharma
Alternative Names: PVT 005; PVT 006Latest Information Update: 28 Jul 2022
Price :
$50
*
At a glance
- Originator IndUS Pharmaceuticals
- Developer BetterLife Pharma
- Class Benzodiazepines; Pyrroles
- Mechanism of Action DNA cross linking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Endometrial cancer; Sexual function disorders; Triple negative breast cancer
Most Recent Events
- 28 Jul 2022 No recent reports of development identified for preclinical development in Sexual-function-disorders in USA
- 28 Jan 2020 No recent reports of development identified for preclinical development in Endometrial-cancer(Metastatic disease) in USA
- 28 Jan 2020 No recent reports of development identified for preclinical development in Triple-negative-breast-cancer in USA